IL17A and COVID-19: Our research group has demonstrated that hDPSCs can modulated the production of cytokines such as TNFα, IFNγ, IL-10 and IL-17A by peripheral blood mononuclear cells (PBMCs) obtained from Coronavirus disease 2019 (COVID-19) patients (16).